The Relationship Between Serum 25(OH)D and Parathyroid Hormone Levels
|
|
- Archibald Williamson
- 6 years ago
- Views:
Transcription
1 CLINICAL RESEARCH STUDY The Relationship Between Serum 25(OH)D and Parathyroid Hormone Levels Walid Saliba, MD, MPH, a Ofra Barnett, PhD, a Hedy S. Rennert, MPH, a Idit Lavi, MA, a Gad Rennert, MD, PhD a,b a Department of Community Medicine and Epidemiology, Carmel Medical Center, Clalit Health Services, and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel; b Department of Epidemiology and Disease Prevention, Office of the Chief Physician, Clalit Health Services Headquarters, Tel Aviv, Israel. ABSTRACT OBJECTIVE: Low 25(OH)D levels are associated with increased parathyroid hormone levels leading to progressive bone loss. The serum levels of 25(OH)D sufficient to keep the parathyroid hormone level at a range that will prevent bone loss are still unclear. The current study was aimed at evaluating the relationship between 25(OH)D levels and concomitant parathyroid hormone levels. METHODS: The computerized laboratory database of Clalit Health Services, a not-for-profit health maintenance organization covering more than half of the Israeli population, was searched for all 25(OH)D and parathyroid hormone tests performed in Concomitant tests of parathyroid hormone and 25(OH)D were identified in 19,172 people. RESULTS: Serum parathyroid hormone levels were inversely correlated with 25(OH)D levels (r 0.176, P.001); 25(OH)D levels less than 50 nmol/l were associated with a steep increase in parathyroid hormone levels and hyperparathyroidism, which decreased with increasing 25(OH)D levels and reached a plateau at 25(OH)D levels of 75 to 85 nmol/l. The quadratic fit with plateau model showed that parathyroid hormone stabilizes at 25(OH)D level of 78.9 nmol/l. However, after excluding 5449 people with hypercalcemia or renal failure, the parathyroid hormone plateau was attained at a significantly lower 25(OH)D cut point of 46.2 nmol/l. CONCLUSION: Our data suggest that a 25(OH)D threshold of 50 nmol/l is sufficient for parathyroid hormone suppression and prevention of secondary hyperparathyroidism in persons with normal renal function. 25(OH)D levels greater than 75 nmol/l do not seem to be associated with additional change in parathyroid hormone levels Elsevier Inc. All rights reserved. The American Journal of Medicine (2011) 124, SEE RELATED EDITORIAL p Vitamin D insufficiency is currently recognized as a worldwide epidemic 1,2 and has been found to be associated with increased morbidity. 3,4 It is widely accepted that vitamin D status is best assessed by serum 25(OH)D. 3,5,6 Because levels of 25(OH)D less than 25 nmol/l are associated with increased risk of rickets and osteomalacia, 5-7 there is a Funding: None. Conflict of Interest: None of the authors have any conflicts of interest associated with the work presented in this manuscript. Authorship: All authors had access to the data and played a role in writing this manuscript. Requests for reprints should be addressed to Walid Saliba, MD, MPH, Department of Community Medicine and Epidemiology, Carmel Medical Center, 7 Michal St, Haifa 34362, Israel. address: saliba_wa@clalit.org.il general agreement that this threshold defines vitamin D deficiency. 3,6 However, there is still lack of consensus on the definition of vitamin D insufficiency and on the physiologic range for its normal function. Because vitamin D controls dietary calcium absorption, even mild insufficiency of vitamin D is compensated by an increase in serum parathyroid hormone, which in turn is associated with increased bone turnover that leads to osteopenia, osteoporosis, and increased risk of fracture. 3-5 Many studies, therefore, use the relationship between serum parathyroid hormone and 25(OH)D to define the normal range of serum 25(OH)D, 4,5,7-11 and different cut points of serum 25(OH)D (37.5 nmol/l, nmol/l, 2,10,11,13 or 75 nmol/l 2,3,5,8 ) are currently in use for insufficiency definition: According to the recently released report on Dietary /$ -see front matter 2011 Elsevier Inc. All rights reserved. doi: /j.amjmed
2 1166 The American Journal of Medicine, Vol 124, No 12, December 2011 Reference Intakes for vitamin D and calcium by the Institute of Medicine (IOM), persons are at risk of deficiency at serum 25(OH)D levels less than 30 nmol/l. Some, but not all, persons are potentially at risk for inadequacy at serum 25(OH)D levels between 30 and 50 nmol/l, and practically all persons are sufficient with serum 25(OH)D levels of at least 50 nmol/l. 14 The lack of a well-established consensus regarding thresholds to be used has clinical implications, and some thresholds may lead to under- or overtreatment. This study assesses the optimal range of serum 25(OH)D by testing the dynamic relationship between 25(OH)D and parathyroid hormone levels. MATERIALS AND METHODS CLINICAL SIGNIFICANCE Study Population and Data Collection Clalit Health Services (CHS) is a not-for-profit health maintenance organization covering more than half of the Israeli population. Data on laboratory tests and demographic variables are available from a computerized database. The study population includes all CHS members for whom 25(OH)D and parathyroid hormone test results performed at the same time in 2009 were available. When more than 1 pair of results was available for the same person, the most recent tests were selected. Paired test results were included only if concomitant serum creatinine and calcium levels also were available for the case, within 8 weeks from the index result. Clinical Definitions Primary hyperparathyroidism was defined as concomitant serum parathyroid hormone 65 pg/ml and serum calcium 10.5 mg/dl. Secondary hyperparathyroidism was defined as concomitant serum parathyroid hormone 65 pg/ml and serum calcium 10.5 mg/dl. Renal failure was defined as serum creatinine 1.5 mg/dl and hypercalcemia as serum calcium 10.5 mg/dl. 25(OH)D and Parathyroid Hormone Assay 25(OH)D and parathyroid hormone were tested in different laboratories; however, more than 90% of the blood tests were performed in 4 central laboratories using the same assay for both tests. 25(OH)D was measured using the LIAISON 25-OH Vitamin D TOTAL assay (DiaSorin USA, Stillwater, Minn), a competitive 2-step chemiluminescence assay with a measurement range of 4.0 to 150 ng/ml ( nmol/l), analytic sensitivity 1.0 ng/ml (2.5 nmol/l), and functional sensitivity 4.0 ng/ml (10 nmol/l). The intra-assay precision is up to 5%, and the inter-assay precision is up to 15%. The specificity is 104% for 25-OH A 25(OH)D threshold of 50 nmol/l is sufficient for parathyroid hormone suppression and prevention of secondary hyperparathyroidism. 25(OH)D levels greater than 75 nmol/l are not associated with additional change in parathyroid hormone levels. By using the threshold of 50 nmol/l, a smaller proportion of the population will be defined as vitamin D insufficient. vitamin D2 and 100% for 25-OH vitamin D3. Parathyroid hormone was measured using the IMMULITE200 intact parathyroid hormone (Siemens USA, New York, NY), a 2-site chemiluminescent enzyme-labeled immunometric assay with a measurement range of 1 to 2500 pg/ml and functional sensitivity of 1 pg/ml. The intra-assay precision is up to 5.7%, and the inter-assay precision is up to 9%. Statistical Analysis Continuous data are presented as mean standard deviation, along with median and interquartile range. Spearman s correlation coefficient was used to test the relation between continuous variables, because some variables, including parathyroid hormone, presented a relatively right-skewed distribution. Continuous variables were compared between 2 groups by the unpaired Student t test or the Mann-Whitney test as appropriate. Logistic regression was used for testing an association between a continuous variable and a prevalence indicator. The mean serum parathyroid hormone is graphically presented in 12 categories (almost equally spaced) of serum 25(OH)D ( 12, 12-25, 25-37, 37-50, 50-62, 62-75, 75-85, 85-95, , , , and 125 nmol/l). A quadratic model with plateau was fitted to model the relationship between serum parathyroid hormone and serum 25(OH)D levels (exact continuous values) to objectively identify the 25(OH)D level where the parathyroid hormone reaches a plateau. This model assumes that for 25(OH)D level less than certain concentration (X 0 ) the equation relating parathyroid hormone and 25(OH)D is quadratic, and for 25(OH)D levels greater than X 0 the equation is constant (at a value P). The model equations thus are parathyroid hormone a b[25(oh)d] c[25(oh)d] 2 for 25(OH)D X 0, and parathyroid hormone P for 25(OH)D X 0. This model was estimated using nonlinear least squares model, as performed by the SAS NLIN procedure (SAS Institute Inc, Cary, NC). The joint point (X 0 ) need not be known for that application. All other statistical analyses were performed using SPSS 17.0 (SPSS Inc, Chicago, Ill). A P value of less than.05 was considered statistically significant. RESULTS Subject Characteristics Complete data were available for 24,109 pairs of serum parathyroid hormone and 25(OH)D test results in 20,045 CHS members who had test results in Included in the analysis are 19,172 members who fulfilled the inclusion
3 Saliba et al Sufficient 25(OH)D Levels 1167 Table 1 Demographic Data and Clinical Characteristics of the Study Population, Clalit Health Services 2009 All (N 19,172) Gender Female 72.0% 79.2% Age Mean SD Median (IQ range) 65.0 (56-75) 63 (54-73) Ethnicity Jews 92.9% 92.8% Arabs 7.1% 7.2% Hypercalcemia 14.1% Impaired renal function 15.8% Primary hyperparathyroidism 8.7% Secondary hyperparathyroidism 31.7% 29.7% SD standard deviation; IQ interquartile. *Creatinine 1.5 mg/dl. Calcium 10.5 mg/dl. Parathyroid hormone 65 pg/ml and calcium 10.5 mg/dl. Parathyroid hormone 65 pg/ml and calcium 10.5 mg/dl. Subjects with Normal Renal Function* and Normal Calcium Levels (N 13,723) criteria. Demographic and clinical characteristics are presented in Table 1. Seventy-two percent are female, and the overall mean age was years. Laboratory tests were equally distributed throughout the different seasons of the year (data not shown). Serum 25(OH)D Levels Serum 25(OH)D ranged between 10 and 375 nmol/l (16 people had levels 200 nmol/l) with a mean of (Table 2). No difference in mean serum 25(OH)D was detected between those with primary hyperparathyroidism compared with those with secondary hyperparathyroidism: and nmol/l, respectively (P 0.240). Mean serum 25(OH)D level was lower in people with renal failure (creatinine 1.5 mg/dl) compared with those with normal renal function: nmol/l and nmol/l, respectively (P.001). Association Between Parathyroid Hormone and 25(OH)D Levels Serum parathyroid hormone levels were weakly and inversely correlated with serum 25(OH)D level (Spearman r 0.176; P.001). The low strength of the correlation may be the result of the nonlinear nature of the association. Serum parathyroid hormone levels increased steeply at 25(OH)D levels less than 50 nmol/l, increased mildly at 25(OH)D level between 50 and 75 nmol/l, and reached a plateau at 25(OH)D levels greater than 75 nmol/l. A segmented model including quadratic equation followed by a plateau was fitted for the whole study group and estimated that serum parathyroid hormone began to increase at serum 25(OH)D less than 78.9 nmol/l (X ). This point corresponded to a serum parathyroid hormone level of 62.5 pg/ml (P 62.5) in all cases tested. The prevalence of hyperparathyroidism (defined as serum parathyroid hormone 65 pg/ml) increased with decreasing serum 25(OH)D (P.001) (data not shown). Association of Parathyroid Hormone with Creatinine and Calcium A significant positive correlation was found between serum parathyroid hormone and serum creatinine levels (Spearman r 0.27; P.001). This correlation was stronger when serum creatinine was greater than 1.5 mg/dl (Spearman r 0.44; P.001). Overall, the correlation of serum parathyroid hormone and serum calcium was significant but weak (Spearman r 0.03; P.001) and negative in those with serum calcium 10.5 mg/dl (r 0.112; P.001). However, for those with hypercalcemia (calcium 10.5 mg/dl) the correlation turned positive and stronger (r 0.284; P.001). Because impaired renal function and increased serum calcium levels were found to be associated with increased serum parathyroid hormone levels, the association between serum parathyroid hormone and 25(OH)D levels was studied separately in people with normal renal function and normal serum calcium (n 13,723). The demographic, clinical, and laboratory characteristics of this subgroup are presented in Tables 1 and 2. The association between serum parathyroid hormone levels by 25(OH)D levels for this subgroup is described in Figure. When the segmented model was fitted to this pop-
4 1168 The American Journal of Medicine, Vol 124, No 12, December 2011 Table 2 Laboratory Data of the Study Population, Clalit Health Services 2009 All (N 19,172) Calcium (mg/dl) Mean SD Median (IQ range) 9.7 ( ) 9.7 (9.4-10) Creatinine (mg/dl) Mean SD Median (IQ range) 0.85 ( ) 0.79 ( ) PTH (pg/ml) All Mean SD Median (IQ range) 56.1 ( ) 49.6 ( ) Winter and Spring Mean SD Median (IQ range) 55.8 ( ) 49.6 ( ) Summer and Autumn Mean SD Median (IQ range) 56.6 ( ) 49.6 ( ) 25(OH)D (nmol/l) All Mean SD Median (IQ range) 61.3 ( ) 62.7 ( ) Winter and Spring Mean SD Median (IQ range) 56.5 ( ) 57.7 ( ) Summer and Autumn Mean SD Median (IQ range 65.5 ( ) 67.3 ( ) SD standard deviation; IQ interquartile; PTH parathyroid hormone. *Creatinine 1.5 mg/dl. Calcium 10.5 mg/dl. No significant difference between seasons for both groups (P.2). Significant difference between seasons for both groups (P.001). Subjects with Normal Renal Function* and Normal Calcium Levels (N 13,723) ulation, the parathyroid hormone plateau was reached at serum parathyroid hormone levels of 53.8 pg/ml (P 53.8), which corresponded with the lower serum 25(OH)D level of 46.2 nmol/l (X ). Figure Mean serum parathyroid hormone (pg/ml) by serum 25(OH)D subgroups, CHS Subjects with normal serum calcium and normal renal function (N 13,723). DISCUSSION Our study shows that the optimal serum 25(OH)D level is approximately 50 nmol/l, as measured by a competitive 2-step chemiluminescence assay, in people with normal kidney function and normal serum calcium levels, if the criteria of plateau serum parathyroid hormone level is accepted as a measure of 25(OH)D adequacy. Parathyroid hormone stabilized at this threshold, and serum 25(OH)D levels greater than 46.2 nmol/l were not associated with continued decrease in parathyroid hormone levels in this group of patients. The 25(OH)D measurement has not been standardized. 15 Binkley et al 16 found that 25(OH)D assays used by different laboratories yielded markedly different results; thus, it should be emphasized that in the present study 25(OH)D was measured by a competitive 2-step chemiluminescence assay. The significant correlation between serum 25(OH)D and serum parathyroid hormone levels is in line with findings in other studies. 4,17 It is suggested that the optimal range of 25(OH)D for skeletal health is one that reduces parathyroid
5 Saliba et al Sufficient 25(OH)D Levels 1169 hormone levels to a minimum. 3 A wide range of normal serum 25(OH)D levels are recommended in the literature, with most estimates clustered from 70 to 80 nmol/l and 40 to 50 nmol/l. 17 Our study identified 2 different 25(OH)D thresholds: 46.2 nmol/l for people with normal creatinine/ calcium and 78.9 nmol/l when no restriction is made. This finding can explain the discrepancy of results reported in the literature. Both renal failure and hypercalcemia were associated with increased parathyroid hormone levels irrespective of vitamin D status. Thus, we suggest the threshold 46.2 nmol/l to define vitamin D sufficiency for parathyroid hormone stabilization. The overall threshold of 78.9 nmol/l in our population is compatible with the findings reported by Holick et al 5 and Chapuy et al. 8 Holick et al 5 used the same model that we used and reported that parathyroid hormone plateaued at 25(OH)D 29.8 ng/ml (equivalent to 74.5 nmol/l). By using an exponential model, Chapuy et al 8 found that serum parathyroid hormone held a stable plateau as long as serum 25(OH)D levels were higher than 78 nmol/l. However, they found no correlation between serum parathyroid hormone and serum creatinine, and concluded that the increase in parathyroid hormone was not secondary to impaired renal function. Okazaki et al 4 recently suggested a 25(OH)D threshold of 28 ng/ml (70 nmol/l). Heaney et al 18 found that intestinal calcium absorption was higher at serum 25(OH)D levels averaging 86.5 nmol/l than at levels averaging 50 nmol/l and concluded that normal serum 25(OH)D levels ranged from 80 to 90 nmol/l. Nevertheless, Hansen et al 19 showed that patients with osteoporosis and vitamin D insufficiency had only 3% increase in fractional calcium absorption after treatment with vitamin D; according to previous studies, this small increase was not associated with decreased risk of hip fracture or increase bone mass. 19 Some studies have suggested higher thresholds. Dawson-Hughes et al 9 found that the change point estimate of 25(OH)D above which the association between parathyroid hormone and 25(OH)D is flat was 110 nmol/l. In line with our suggested threshold of 25(OH)D at approximately 50 nmol/l as measured by a competitive 2-step chemiluminescence assay, Malabanan et al 10 found that supplementation with oral vitamin D 2 and oral calcium decreased serum parathyroid hormone only in subjects with basal serum 25(OH)D levels of less than 50 nmol/l, and concluded that this threshold was the minimum required to optimize serum parathyroid hormone and prevent secondary hyperparathyroidism. The same threshold was suggested by Lips et al 11 from the reanalysis of the MORE trial. Recently, this threshold was defined as the minimum required to support and maintain normal bone and mineral health by the 14th Vitamin D Workshop held in Brugge Belgium in October Moreover, the recently released IOM report concluded that a serum 25(OH)D level of at least 50 nmol/l is practically sufficient for everyone. 14 Other studies found lower thresholds. Thomas et al 21 found that parathyroid hormone increased steeply as serum 25(OH)D declined to less than 15 ng/ml (37.5 nmol/l), and that for levels greater than 37.5 nmol/l the slope was not significantly different from zero (P.13). It is possible that the wide range of previously suggested thresholds may reflect different demographic 22 and clinical characteristics of the studied populations, as well as the statistical models used and the assay used to measure 25(OH)D levels. The strength of our study is in the large number of parathyroid hormone/25(oh)d paired test results that were available from a large general population with demographic heterogeneity. Also, the studied tests were equally distributed among the seasons of the year. Another strength of the study is that we were able to evaluate the influence of serum calcium levels and renal function status on the parathyroid hormone/25(oh)d relationship. Yet, the current study also has several limitations: data on calcium intake, body mass index, and serum magnesium, all known to influence serum parathyroid hormone levels, were not available. Our study used the total serum calcium level and not the more accurate ionized calcium or calcium corrected to serum albumin. Renal function assessment was based on creatinine levels rather than by the more accurate glomerular filtration rate. The individual timing of blood collection for parathyroid hormone testing was not available; however, the instructions state that the blood sample should be collected in the morning after an overnight fast. Another limitation of our study is that we were not able to identify and exclude from the analysis patients taking medication that may affect 25(OH)D levels, such as anticonvulsants and glucocorticoids. Normal serum parathyroid hormone levels are influenced by serum 25(OH)D levels. 15 Some data suggest lower thresholds of serum parathyroid hormone levels in vitamin D-replete subjects. 23 In this study, we used a serum parathyroid hormone level greater than 65 pg/ml to define hyperparathyroidism in all patients irrespective of their individual serum 25(OH)D levels. However, we still do not have optimal reference intervals for parathyroid hormone values based on coexisting 25(OH)D levels. 15 Moreover, a large proportion of the population included in our study were vitamin D depleted and are expected to have higher parathyroid hormone levels. It should be emphasized that we did not have data on bone density and therefore cannot state if the limit increase in parathyroid hormone also was associated with a limit in influence on bone density. Vitamin D deficiency, usually based on high thresholds of 75 nmol/l, is an increasingly described phenomenon affecting the majority of Western populations, and drastic corrective measures are often recommended. 2,3,5,8 Our finding, that 25(OH)D levels greater than 46.2 nmol/l seem to be sufficient, is in line with those of the recent IOM report, which also suggested that even lower levels may be adequate for some. In light of these findings, it seems that a smaller proportion of the population will be defined as vitamin D insufficient.
6 1170 The American Journal of Medicine, Vol 124, No 12, December 2011 CONCLUSIONS 25(OH)D levels greater than 46.2 nmol/l seem to be sufficient for suppression of parathyroid hormone and prevention of secondary hyperparathyroidism. 25(OH)D levels greater than 75 nmol/l do not seem to be associated with additional change in parathyroid hormone levels. More studies are needed to identify the optimal level of 25(OH)D in correlation with clinical outcomes. References 1. Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357: Mithal A, Wahl DA, Bonjour JP, et al; IOF Committee of Scientific Advisors (CSA) Nutrition Working Group. Global vitamin D status and determinants of hypovitaminosis D. Osteoporos Int. 2009;20: Holick MF. High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc. 2006;81: Okazaki R, Sugimoto T, Kaji H, et al. Vitamin D insufficiency defined by serum 25-hydroxyvitamin D and parathyroid hormone before and after oral vitamin D(3) load in Japanese subjects. J Bone Miner Metab. 2011;29: Epub 2010 Jun Holick MF, Siris ES, Binkley N, et al. Prevalence of vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. J Clin Endocrinol Metab. 2005;90: Pearce SH, Cheetham TD. Diagnosis and management of vitamin D deficiency. BMJ. 2010;340: Carnevale V, Nieddu L, Romagnoli E, et al. Regulation of PTH secretion by 25-hydroxyvitamin D and ionized calcium depends on vitamin D status: a study in a large cohort of healthy subjects. Bone. 2010: Chapuy MC, Preziosi P, Maamer M, et al. Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos Int. 1997;7: Dawson-Hughes B, Harris SS, Dallal GE. Plasma calcidiol, season, and serum parathyroid hormone concentrations in healthy elderly men and women. Am J Clin Nutr. 1997;65: Malabanan A, Veronikis IE, Holick MF. Redefining vitamin D insufficiency. Lancet. 1998;351: Lips P, Duong T, Oleksik A, et al. A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from the multiple outcomes of raloxifene evaluation clinical trial. J Clin Endocrinol Metab. 2001;86: Nesby-O Dell S, Scanlon KS, Cogswell ME, et al. Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: Third National Health and Nutrition Examination Survey, Am J Clin Nutr. 2002;76: Yetley EA. Assessing the vitamin D status of the US population. Am J Clin Nutr. 2008;88:558S-564S. 14. National Academy of Science, Institute of Medicine (2010). Dietary references intake for calcium and vitamin D. Available at: Accessed January 8, Eastell R, Arnold A, Brandi ML, et al. Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab. 2009;94: Binkley N, Krueger D, Cowgill CS, et al. Assay variation confounds the diagnosis of hypovitaminosis D: a call for standardization. J Clin Endocrinol Metab. 2004;89: Aloia JF, Talwar SA, Pollack S, et al. Optimal vitamin D status and serum parathyroid hormone concentrations in African American women. Am J Clin Nutr. 2006;84: Heaney RP, Dowell MS, Hale CA, Bendich A. Calcium absorption varies within the reference range for serum 25-hydroxyvitamin D. J Am Coll Nutr. 2003;22: Hansen KE, Jones AN, Lindstrom MJ, et al. Vitamin D insufficiency: disease or no disease? J Bone Miner Res. 2008;23: Henry HL, Bouillon R, Norman AW, et al. 14th Vitamin D Workshop consensus on vitamin D nutritional guidelines. J Steroid Biochem Mol Biol. 2010;121: Thomas MK, Lloyd-Jones DM, Thadhani RI, et al. Hypovitaminosis D in medical inpatients. N Engl J Med. 1998;338: Saliba W, Rennert HS, Kershenbaum A, Rennert G. Serum 25(OH)D concentrations in sunny Israel. Osteoporos Int DOI: / s y. 23. Souberbielle JC, Lawson-Body E, Hammadi B, et al. The use in clinical practice of parathyroid hormone normative values established in vitamin D-sufficient subjects. J Clin Endocrinol Metab. 2003;88:
ESPEN Congress Prague 2007
ESPEN Congress Prague 2007 Key papers in the field of nutrition Dietitian Geila S Rozen Key Papers in the field of Nutrition ESPEN 2007 Prague Geila S Rozen Clinical Nutrition Dep. Rambam health campus
More informationVitamin D Status of an Outpatient Clinic Population
Calcif Tissue Int (2001) 69:263 267 DOI: 10.1007/s002230010054 2001 Springer-Verlag New York Inc. Vitamin D Status of an Outpatient Clinic Population L. Margiloff, 1 S. S. Harris, 2 S. Lee, 3 R. Lechan,
More informationVitamin D Therapy in Patients with Primary Hyperparathyroidism and Hypovitaminosis D
Page 1 of 17 Accepted Preprint first posted on 21 April 2009 as Manuscript EJE-08-0901 Vitamin D Therapy in Patients with Primary Hyperparathyroidism and Hypovitaminosis D JR Tucci, MD, FACP, FACE, Director,
More informationVitamin D therapy in patients with primary hyperparathyroidism and hypovitaminosis D
European Journal of Endocrinology (2009) 161 189 193 ISSN 0804-4643 CLINICAL STUDY Vitamin D therapy in patients with primary hyperparathyroidism and hypovitaminosis D J R Tucci 1,2,3 1 Division of Endocrinology,
More informationAppropriate Goal Level for 25-Hydroxyvitamin D in Cystic Fibrosis
CHEST Appropriate Goal Level for 25-Hydroxyvitamin D in Cystic Fibrosis Original Research Natalie E. West, MD, MHS; Noah Lechtzin, MD, MHS, FCCP; Christian A. Merlo, MD, MPH; Jason B. Turowski, MD; Marsha
More informationVitamin D. Vitamin functioning as hormone. Todd A Fearer, MD FACP
Vitamin D Vitamin functioning as hormone Todd A Fearer, MD FACP Vitamin overview Vitamins are organic compounds that are essential in small amounts for normal metabolism They are different from minerals
More informationElecsys bone marker panel. Optimal patient management starts in the laboratory
bone marker panel Optimal patient management starts in the laboratory Complete solution for osteoporosis The most complete bone metabolism panel on a single platform bone marker assays are important diagnostic
More informationMEDICAL POLICY EFFECTIVE DATE: 08/21/14 REVISED DATE: 04/16/15, 06/16/16, 07/20/17 SUBJECT: SCREENING FOR VITAMIN D DEFICIENCY
MEDICAL POLICY SUBJECT: SCREENING FOR VITAMIN D DEFICIENCY A nonprofit independent licensee of the BlueCross BlueShield Association PAGE: 1 OF: 5 If a product excludes coverage for a service, it is not
More informationSerum 25-hydroxyvitamin D and parathyroid hormone exhibit threshold behavior
J. Endocrinol. Invest. 28: 180-182, 2005. OPINION Serum 25-hydroxyvitamin D and parathyroid hormone exhibit threshold behavior R.P. Heaney Creighton University, Omaha, Nebraska,USA Most reported studies
More informationTHE NEW ZEALAND MEDICAL JOURNAL
THE NEW ZEALAND MEDICAL JOURNAL Vol 116 No 1179 ISSN 1175 8716 Efficacy of an oral, 10-day course of high-dose calciferol in correcting vitamin D deficiency Fiona Wu, Toni Staykova, Anne Horne, Judy Clearwater,
More informationVitamin D and Calcium
Vitamin D and Calcium American Association of Clinical Endocrinologists Marina Del Rey, CA September 15, 2018 Albert Shieh, MD MS Assistant Clinical Professor Department of Medicine Division of Endocrinology
More informationSerum vitamin D metabolites and intestinal calcium absorption efficiency in women 1 3
See corresponding editorial on page 673. Serum vitamin D metabolites and intestinal calcium absorption efficiency in women 1 3 John F Aloia, Ding-Geng Chen, James K Yeh, and Henian Chen ABSTRACT Background:
More informationThe Impact of Life Style & Dietary Habits on Vitamin D status Among Young Emiratis. Fatme Al Anouti, Ph.D. Zayed University, Abu Dhabi
The Impact of Life Style & Dietary Habits on Vitamin D status Among Young Emiratis Fatme Al Anouti, Ph.D. Zayed University, Abu Dhabi The Sun-Shine Vitamin Vitamin D is unique because it can be synthesized
More informationoriginal Se Hwa Kim 1), Tae Ho Kim 1) and Soo-Kyung Kim 2)
Endocrine Journal 2014, 61 (12), 1197-1204 original Effect of high parathyroid hormone level on bone mineral density in a vitamin D-sufficient population: Korea National Health and Nutrition Examination
More informationVitamin D and Calcium Therapy: how much is enough
Vitamin D and Calcium Therapy: how much is enough Daniel D Bikle, MD, PhD Professor of Medicine VA Medical Center and University of California San Francisco DISCLOSURE Nothing to disclose 1 RECOMMENDATIONS
More informationThe Endocrine Society Guidelines
Vitamin D and Calcium Therapy: how much is enough DISCLOSURE Daniel D Bikle, MD, PhD Professor of Medicine VA Medical Center and University of California San Francisco Nothing to disclose RECOMMENDATIONS
More informationSkeletal Manifestations
Skeletal Manifestations of Metabolic Bone Disease Mishaela R. Rubin, MD February 21, 2008 The Three Ages of Women Gustav Klimt 1905 1 Lecture Outline Osteoporosis epidemiology diagnosis secondary causes
More informationZeenat Ali, PGY3 Joseph Grisanti, MD June 7 th, 2012
A Randomized Open Label Trial to Evaluate the Efficacy of Different Dosage Forms of Vitamin D in Patients with Vitamin D Deficiency, and the Effect of Food on Vitamin D Absorption. Zeenat Ali, PGY3 Joseph
More informationVITAMIN D AND THE ATHLETE
VITAMIN D AND THE ATHLETE CONSIDERATIONS FOR THE PRACTITIONER Written by Bruce Hamilton, Qatar Vitamin D is a steroid hormone that has previously been given little attention, partially as a result of its
More informationTHE PREVALENCE OF HYPOVITAMINOSIS D AMONG US ADULTS: DATA FROM THE NHANES III
THE PREVALENCE OF HYPOVITAMINOSIS D AMONG US ADULTS: DATA FROM THE NHANES III Objective: Several epidemiologic and mechanistic studies suggest that 25(OH) D 3 levels should be maintained above 70 nmol/l
More informationJOURNAL OF INTERNATIONAL ACADEMIC RESEARCH FOR MULTIDISCIPLINARY Impact Factor 1.393, ISSN: , Volume 2, Issue 7, August 2014
HYPOVITAMINOSIS D IN INDIAN FEMALES WITH POSTMENOPAUSAL OSTEOPOROSIS DR. SHAH WALIULLAH 1 DR. VINEET SHARMA 2 DR. R N SRIVASTAVA 3 DR. YASHODHARA PRADEEP 4 DR. A A MAHDI 5 DR. SANTOSH KUMAR 6 1 Research
More informationTHE IMPORTANCE OF ADEQUATE
ORIGINAL CONTRIBUTION Relationship Between Serum Parathyroid Hormone Levels, Vitamin D Sufficiency, and Calcium Intake Laufey Steingrimsdottir, PhD Orvar Gunnarsson, MD Olafur S. Indridason, MD, MHS Leifur
More informationThe Skeletal Response to Aging: There s No Bones About It!
The Skeletal Response to Aging: There s No Bones About It! April 7, 2001 Joseph E. Zerwekh, Ph.D. Interrelationship of Intestinal, Skeletal, and Renal Systems to the Overall Maintenance of Normal Calcium
More informationDBC 25-Hydroxyvitamin D
D I A G N O S T I C S B I O C H E M C A N A D A DBC 25-Hydroxyvitamin D ELISA OVERVIEW The worldwide aging and chronically ill population is increasing rapidly. It is forecasted that the Global Vitamin
More informationBone and Mineral. Comprehensive Menu for the Management of Bone and Mineral Related Diseases
Bone and Mineral Comprehensive Menu for the Management of Bone and Mineral Related Diseases Innovation to Assist in Clinical Diagnosis and Treatment DiaSorin offers a specialty line of Bone and Mineral
More informationEstimation of the cutoff value of vitamin D: the Dong-gu study
Choi et al. Journal of Physiological Anthropology (2015) 34:10 DOI 10.1186/s40101-015-0048-4 SHORT REPORT Open Access Estimation of the cutoff value of vitamin D: the Dong-gu study Seong-Woo Choi 1, Sun-Seog
More informationThe effect of sun exposure on 25-hydroxyvitamin D concentrations in young healthy subjects living in the city of São Paulo, Brazil
Brazilian Journal of Medical and Biological Research (2007) 40: 1653-1659 25-Hydroxyvitamin D status in young healthy subjects ISSN 0100-879X 1653 The effect of sun exposure on 25-hydroxyvitamin D concentrations
More informationThe Vitamin D Gap. Vitamin D intake guidelines were established to prevent. Estimating an adequate intake of vitamin D. FEATURE VITAMIN D GAP
The Vitamin D Gap Estimating an adequate intake of vitamin D. By Laurence Montgomery, ND and George Tardik, ND Vitamin D intake guidelines were established to prevent rickets in children and osteomalacia
More informationDescription of Study Protocol. Data Collection Summary
AND Evidence Analysis Worksheet Citation Kostoglou-athanassiou I, AthanassiouP, Lyraki A, Raftakis I, Antoniadis C. Vitamin D and rheumatoid arthritis. Ther Adv Endocrinol Metab. 2012; 3(6):181-7. Study
More informationOriginal Article. Elizabeth Kos, MD 1 ; Mary Jo Liszek, MD 2 ; Mary Ann Emanuele, MD 3 ; Ramon Durazo-Arvizu, PhD 4 ; Pauline Camacho, MD, FACE 3
Original Article Elizabeth Kos, MD 1 ; Mary Jo Liszek, MD 2 ; Mary Ann Emanuele, MD 3 ; Ramon Durazo-Arvizu, PhD 4 ; Pauline Camacho, MD, FACE 3 ABSTRACT Objective: To determine the effect of metformin
More informationV t i amin i n D a nd n d Calc l iu i m u : Rol o e l in i n Pr P eve v nt n io i n and n d Tr T eatment n of o Fr F actur u es and n d Fa F ll l s
Vitamin D and Calcium: Role in Prevention and Treatment of Fractures and Falls Osteoporosis 21: New Insights In Research, Diagnosis, and Clinical Care Deborah Sellmeyer, MD Director, Johns Hopkins Metabolic
More informationBAD TO THE BONE. Peter Jones, Rheumatologist QE Health, Rotorua. GP CME Conference Rotorua, June 2008
BAD TO THE BONE Peter Jones, Rheumatologist QE Health, Rotorua GP CME Conference Rotorua, June 2008 Agenda Osteoporosis in Men Vitamin D and Calcium Long-term treatment with Bisphosphonates Pathophysiology
More informationVitamin D intake to attain a desired serum 25-hydroxyvitamin D concentration 1 3
Vitamin D intake to attain a desired serum 25-hydroxyvitamin D concentration 1 3 John F Aloia, Manish Patel, Rhett DiMaano, Melissa Li-Ng, Sonia A Talwar, Mageda Mikhail, Simcha Pollack, and James K Yeh
More informationEastern Paediatric Epilepsy Network
1. Objective 2. Background 3. Vitamin D and epilepsy 4. Monitoring and optimizing bone health in healthy children 5. 6. Recommendations 1.) Objective: 1.1) To provide a rational basis for monitoring bone
More informationOriginal Article The epidemic investigation of serum 25-hydroxy vitamin D levels in the adults in Qujing area of Yunnan province in China
Int J Clin Exp Pathol 2015;8(8):9597-9601 www.ijcep.com /ISSN:1936-2625/IJCEP0013259 Original Article The epidemic investigation of serum 25-hydroxy vitamin D levels in the adults in Qujing area of Yunnan
More informationOSTEOMALACIA UPDATE. Nothing to Disclose. Daniel D Bikle, MD, PhD Professor of Medicine University of California and VA Medical Center San Francisco
OSTEOMALACIA UPDATE Daniel D Bikle, MD, PhD Professor of Medicine University of California and VA Medical Center San Francisco Nothing to Disclose 1 Case History 59 YO WM referred for evaluation of diffuse
More informationGeographical differences in vitamin D status, with particular reference to European countries
Proceedings of the Nutrition Society (2003), 62, 813 821 The Authors 2003 CAB PNS 821 9 Nutrition 297Optimum InternationalPNSProceedings Society nutrition 2003 for osteoporosis of Nutrition preventionl.
More informationStudy of secondary causes of male osteoporosis
Study of secondary causes of male osteoporosis Suárez, S.M., Giunta J., Meneses G., Costanzo P.R., Knoblovits P. Department of Endocrinology, Metabolism and Nuclear Medicine of Hospital Italiano of Buenos
More informationVitamin D Status among Patients Attending Hussein Medical Center for Diabetes in Jordan
Vitamin D Status among Patients Attending Hussein Medical Center for Diabetes in Jordan Muwafag Hyari MD*, Hala Abu-Romman MD ** ABSTRACT Objective: Vitamin D is a steroid fat soluble vitamin, in which
More informationVitamin D Deficiency. Decreases renal calcium excretion. Increases intestinal absorption Calcium. Increases bone resorption of calcium
Vitamin D Deficiency Deborah Gordish, MD Assistant Professor of Clinical Internal Medicine Lead Physician Lewis Center Primary Care Associate Division Director General Internal Medicine The Ohio State
More informationClinical Policy: Measurement of Serum 1,25-dihydroxyvitamin D
Clinical Policy: Reference Number: CP.MP.152 Last Review Date: 12/17 Coding Implications Revision Log See Important Reminder at the end of this policy for important regulatory and legal information. Description
More informationFOR CONSUMERS AND PATIENTS
AVAILABILITY OF VITAMIN D FOR CONSUMERS AND PATIENTS Prof. Heike A. Bischoff-Ferrari, MD, DrPH Centre on Aging and Mobility, University of Zurich Dept. of Rheumatology, University Hospital Zurich Overview
More informationVitamin D Deficiency in Patients presented in Medical OPD with Fibromyalgia Muhammad Arif Mahmood, Muhammad Arshad Qureshi, Ijaz-Ul-Haque Taseer
Original Article Vitamin D Deficiency in Patients presented in Medical OPD with Fibromyalgia Muhammad Arif Mahmood, Muhammad Arshad Qureshi, Ijaz-Ul-Haque Taseer ABSTRACT Objectives: To determine the prevalence
More informationCIC EDIZIONI INTERNAZIONALI. Vitamin D supplementation in fractured patient: how, when and why. Mini review
Vitamin D supplementation in fractured patient: how, when and why Giovanni Iolascon, MD a G. Di Pietro, MD b F. Gimigliano, MD, PhD c Department of Orthopedics and Rehabilitation, Second University of
More informationVitamin D: Conflict of Interest Statement Corporate. Outline 7/5/2016
Vitamin D: What s New and Not? Clifford J Rosen MD Maine Medical Center Research Institute rosenc@mmc.org Conflict of Interest Statement Corporate NO STOCKS or EQUITY Editor UpToDate, New England Journal
More information25 OH Vitamin D Rapid Test
INSTRUCTION FOR USE REF:GDB 7120-25T 25 OH Vitamin D Rapid Test A Rapid Sandwich Immunochromatographic Test for Quantitative Detection of total 25-OH Vitamin D in human finger-prick blood For In Vitro
More informationUrgent action needed to improve vitamin D status among older people in England!
Age and Ageing 2010; 39: 62 68 The Author 2009. Published by Oxford University Press on behalf of the British Geriatrics Society. doi: 10.1093/ageing/afp195 All rights reserved. For Permissions, please
More informationHuman serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol 1 3
Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol 1 3 Robert P Heaney, K Michael Davies, Tai C Chen, Michael F Holick, and M Janet Barger-Lux ABSTRACT Background:
More informationORIGINAL ARTICLE. O. M. Gutiérrez & W. R. Farwell & D. Kermah & E. N. Taylor
DOI 10.1007/s00198-010-1383-2 ORIGINAL ARTICLE Racial differences in the relationship between vitamin D, bone mineral density, and parathyroid hormone in the National Health and Nutrition Examination Survey
More informationVitamin D deficiency in Korean children: prevalence, risk factors, and the relationship with parathyroid hormone levels
Original article http://dx.doi.org/10.6065/apem.2014.19.2.86 Ann Pediatr Endocrinol Metab 2014;19:86-91 Vitamin D deficiency in Korean children: prevalence, risk factors, and the relationship with parathyroid
More informationBone Health in Celiac Disease. Partha S. Sinha MD, PhD October 29 th, 2017
Bone Health in Celiac Disease Partha S. Sinha MD, PhD October 29 th, 2017 No Disclosures Objectives Recognize the mechanisms by which celiac disease can affect bone health Review what diagnostic tests
More informationEndocrine Regulation of Calcium and Phosphate Metabolism
Endocrine Regulation of Calcium and Phosphate Metabolism Huiping Wang ( 王会平 ), PhD Department of Physiology Rm C516, Block C, Research Building, School of Medicine Tel: 88208252 Email: wanghuiping@zju.edu.cn
More informationSupplementary Online Content
Supplementary Online Content Bischoff-Ferrari HA, Dawson-Hughes B, Orav EJ, et al. Monthly high-dose vitamin D treatment for the prevention of functional decline: a randomized clinical trial. JAMA Intern
More informationCorporate Medical Policy
Corporate Medical Policy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: testing_serum_vitamin_d_levels 9/2015 2/2018 2/2019 2/2018 Description of Procedure or Service Vitamin D,
More informationThe Role of the Laboratory in Metabolic Bone Disease
The Role of the Laboratory in Metabolic Bone Disease Howard Morris PhD, FAACB, FFSc(RCPA) President, IFCC Professor of Medical Sciences, University of South Australia, Clinical Scientist, SA Pathology
More informationAssessment of Musculoskeletal Pain among Patients with Vitamin D Deficiency
Original article: Assessment of Musculoskeletal Pain among Patients with Vitamin D Deficiency Dr. Devendra Kumar Kundara Junior Specialist (General Medicine), D.B. Hospital, Churu, Rajasthan, India. Corresponding
More informationAPPLIED NUTRITIONAL INVESTIGATION INTRODUCTION
APPLIED NUTRITIONAL INVESTIGATION Low Serum Concentrations of 25-Hydroxyvitamin D in Young Adult Japanese Women: A Cross Sectional Study Kazutoshi Nakamura, MD, MPH, Mitsue Nashimoto, BA, Shigeki Matsuyama,
More informationVitamin D supplementation: what is right?
Mini-review Daniel Alvarez-Hernández Carlos Gómez-Alonso Jorge B. Cannata-Andía Servicio de Metabolismo Óseo y Mineral Instituto Reina Sofía de Investigación Hospital Universitario Central de Asturias,
More informationApproach to a patient with hypercalcemia
Approach to a patient with hypercalcemia Ana-Maria Chindris, MD Division of Endocrinology Mayo Clinic Florida 2013 MFMER slide-1 Background Hypercalcemia is a problem frequently encountered in clinical
More informationPRIMARY HYPERPARATHYROIDISM PRIMARY HYPERPARATHYROIDISM. Hyperparathyroidism Etiology. Common Complex Insidious Chronic Global Only cure is surgery
ENDOCRINE DISORDER PRIMARY HYPERPARATHYROIDISM Roseann P. Velez, DNP, FNP Francis J. Velez, MD, FACS Common Complex Insidious Chronic Global Only cure is surgery HYPERPARATHYROIDISM PARATHRYOID GLANDS
More information25(OH) Vitamin D ELISA (BD-220BA), 192 Tests
INTENDED USE The 25-hydroxy (25-OH) Vitamin D ELISA is intended for the quantitative determination of total 25-OH Vitamin D in human serum and Plasma. SUMMARY AND EXPLANATION Vitamin D is a steroid hormone
More informationPrevalence of Vitamin D Inadequacy among Postmenopausal North American Women Receiving Osteoporosis Therapy
0021-972X/05/$15.00/0 The Journal of Clinical Endocrinology & Metabolism 90(6):3215 3224 Printed in U.S.A. Copyright 2005 by The Endocrine Society doi: 10.1210/jc.2004-2364 Prevalence of Vitamin D Inadequacy
More informationDo We Do Too Many Parathyroidectomies in Dialysis? Sagar Nigwekar MD, MMSc Massachusetts General Hospital
Do We Do Too Many Parathyroidectomies in Dialysis? Sagar Nigwekar MD, MMSc Massachusetts General Hospital E-mail: snigwekar@mgh.harvard.edu March 13, 2017 Disclosures statement: Consultant: Allena, Becker
More informationVitamin D: Is it a superhero??
Vitamin D: Is it a superhero?? Dr. Ashraf Abdel Basset Bakr Prof. of Pediatrics 1 2 History of vitamin D discovery Sources of vitamin D and its metabolism 13 Actions of vitamin D 4 Vitamin D deficiency
More informationCorporate Medical Policy
Corporate Medical Policy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: testing_serum_vitamin_d_levels 9/2015 2/2017 2/2018 2/2017 Description of Procedure or Service Vitamin D,
More informationHigh prevalence of vitamin D insufficiency or deficiency in young adolescents in Korea
Eur J Pediatr (2012) 171:1475 1480 DOI 10.1007/s00431-012-1746-0 ORIGINAL ARTICLE High prevalence of vitamin D insufficiency or deficiency in young adolescents in Korea Youn Ho Shin & Ki Eun Kim & Choae
More informationCALCIUM INTAKE MAY be one of the many factors that
0021-972X/05/$15.00/0 The Journal of Clinical Endocrinology & Metabolism 90(2):707 711 Printed in U.S.A. Copyright 2005 by The Endocrine Society doi: 10.1210/jc.2004-1380 Lack of Effect of Calcium Intake
More informationVITAMIN D IN HEALTH AND DISEASE
VITAMIN D IN HEALTH AND DISEASE Margus Lember University of Tartu, Estonia ESIM, Saas Fee, January 16, 2014 l It`s most healthy to live on the southern side of a mountain l Hippokrates of Kos 460-370 BC
More informationHyperparathyroidism: Operative Considerations. Financial Disclosures: None. Hyperparathyroidism. Hyperparathyroidism 11/10/2012
Hyperparathyroidism: Operative Considerations Financial Disclosures: None Steven J Wang, MD FACS Associate Professor Dept of Otolaryngology-Head and Neck Surgery University of California, San Francisco
More informationLast Review Status/Date: December Summary
Subsection: Pathology/Laboratory Original Policy Date: September 18, 2015 Subject: Testing Serum Vitamin D Levels Page: 1 of 15 Last Review Status/Date: December 2015 Summary Vitamin D, also known as calciferol,
More informationUpdate on vitamin D. J Chris Gallagher Professor of Medicine and Endocrinology Creighton University Omaha,Nebraska USA
Update on vitamin D J Chris Gallagher Professor of Medicine and Endocrinology Creighton University Omaha,Nebraska 68131 USA Cali, Colombia 2016 definitions DRIs are the recommended dietary reference intakes
More informationSteven A Abrams, Keli M Hawthorne, and Zhensheng Chen
Supplementation with 1000 IU vitamin D/d leads to parathyroid hormone suppression, but not increased fractional calcium absorption, in 4 8-y-old children: a double-blind randomized controlled trial 1 4
More informationAssociation of A1c Levels with Vitamin D Status in U.S. Adults: Data from the National Health and Nutrition Examination Survey
Diabetes Care Publish Ahead of Print, published online March 9, 2010 Vitamin D Status and A1c Levels Association of A1c Levels with Vitamin D Status in U.S. Adults: Data from the National Health and Nutrition
More informationResponse to Teriparatide in Patients with Baseline 25- Hydroxyvitamin D Insufficiency or Sufficiency
J Clin Endocrin Metab. First published ahead of print October 2, 2007 as doi:10.1210/jc.2007-0239 Response to Teriparatide in Patients with Baseline 25- Hydroxyvitamin D Insufficiency or Sufficiency Bess
More informationVitamin D Deficiency in Adults: When to Test and How to Treat. Kurt A. Kennel, MD; Matthew T. Drake, MD, PhD; and Daniel L.
CONCISE REVIEW FOR CLINICIANS VITAMIN D DEFICIENCY IN ADULTS Vitamin D Deficiency in Adults: When to Test and How to Treat Kurt A. Kennel, MD; Matthew T. Drake, MD, PhD; and Daniel L. Hurley, MD Recent
More informationIntroduction. Nephrol Dial Transplant (2012) 27: doi: /ndt/gfr535 Advance Access publication 22 September 2011
Nephrol Dial Transplant (2012) 27: 1950 1956 doi: 10.1093/ndt/gfr535 Advance Access publication 22 September 2011 Interpretation of serum PTH concentrations with different kits in dialysis according to
More informationAssociation between serum 25-hydroxyvitamin D and depressive symptoms in Japanese: analysis by survey season
University of Massachusetts Amherst From the SelectedWorks of Kalpana Poudel-Tandukar Summer August 19, 2009 Association between serum 25-hydroxyvitamin D and depressive symptoms in Japanese: analysis
More informationHellenic Endocrine Society position statement: Clinical management of Vitamin D Deficiency. Spyridon Karras MD, Phd Endocrinologist
Hellenic Endocrine Society position statement: Clinical management of Vitamin D Deficiency Spyridon Karras MD, Phd Endocrinologist Pregnancy We recommend a minimum intake of 600 international units of
More informationVitamin D. Mrs Sophie Barnes FRCPath Consultant Clinical Scientist
Vitamin D Mrs Sophie Barnes FRCPath Consultant Clinical Scientist Learning objectives Biochemistry and physiology of vitamin D Causes and consequences of vitamin D deficiency Current and anticipated guidelines
More informationMedical Policy Vitamin D Screening and Testing
Medical Policy Vitamin D Screening and Testing Subject: Vitamin D Screening and Testing Background: Vitamin D is a prohormone that is inactive until converted (in the liver) to 25-hydroxyvitamin D (25[OH]D;
More informationNIH Public Access Author Manuscript J Am Coll Nutr. Author manuscript; available in PMC 2009 August 20.
NIH Public Access Author Manuscript Published in final edited form as: J Am Coll Nutr. 2008 April ; 27(2): 274 279. Body size and serum 25 hydroxy vitamin D response to oral supplements in healthy older
More informationCorrecting poor vitamin D status: Do older adults need higher repletion doses of vitamin D 3 than younger adults?
Mol. Nutr. Food Res. 2010, 54, 1 8 DOI 10.1002/mnfr.200900536 1 REVIEW Correcting poor vitamin D status: Do older adults need higher repletion doses of vitamin D 3 than younger adults? Susan J. Whiting
More informationThe effect of supplementation with vitamin D on recurrent ischemic events and sudden cardiac death in patients with acute coronary syndrome
CRC IRB Proposal Matthew Champion PGY-1 8/29/12 The effect of supplementation with vitamin D on recurrent ischemic events and sudden cardiac death in patients with acute coronary syndrome Study Purpose
More informationCurrent Concepts in the Evaluation and Management of Abnormal Parathyroid Hormone (PTH) Levels Shireen Fatemi, M.D. April, 2012.
Current Concepts in the Evaluation and Management of Abnormal Parathyroid Hormone (PTH) Levels Shireen Fatemi, M.D. April, 2012 Disclosures I have no financial relationships with commercial interests,
More informationAnalytical Methods: the Kidney Early Evaluation Program (KEEP) The Kidney Early Evaluation program (KEEP) is a free, community based health
Analytical Methods: the Kidney Early Evaluation Program (KEEP) 2000 2006 Database Design and Study Participants The Kidney Early Evaluation program (KEEP) is a free, community based health screening program
More informationJMSCR Vol 06 Issue 12 Page December 2018
www.jmscr.igmpublication.org Impact Factor (SJIF): 6.379 Index Copernicus Value: 79.54 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v6i12.157 A comparative study of two
More informationDr Seeta Durvasula.
Dr Seeta Durvasula seeta.durvasula@sydney.edu.au 1 Avoid sun skin cancer risk Australia has highest rates of skin cancer in the world Epidemic of Vitamin D deficiency Lack of Vitamin D increases risk of
More informationAvailable online at ScienceDirect. Osteoporosis and Sarcopenia 1 (2015) 121e126. Original article
HOSTED BY Available online at www.sciencedirect.com ScienceDirect Osteoporosis and Sarcopenia 1 (2015) 121e126 Original article What is an appropriate dosage and interval of vitamin D 2 supplementation
More informationVitamin D Deficiency. Micol Rothman, MD Assistant Professor of Medicine Clinical Director Metabolic Bone Program University of CO-Denver
Vitamin D Deficiency Micol Rothman, MD Assistant Professor of Medicine Clinical Director Metabolic Bone Program University of CO-Denver 50 yo woman referred for osteoporosis What is striking about her
More informationVitamin D deficiency is associated with longer hospital stay and lower functional outcome after total knee arthroplasty.
Reference number to be mentioned by correspondence : ORTHO/- Acta Orthop. Belg., 2015, 83, 00-00 ORIGINAL STUDY Vitamin D deficiency is associated with longer hospital stay and lower functional outcome
More information25-Hydroxy Vitamin D Deficiency Following Pediatric Hematopoietic Stem Cell Transplant
25-Hydroxy Vitamin D Deficiency Following Pediatric Hematopoietic Stem Cell Transplant Christine N. Duncan, Lynda Vrooman, Erin M. Apfelbaum, Katherine Whitley, Lori Bechard, Leslie E. Lehmann Children
More informationVitamin D, Sunlight Exposure, and Bone Density in Elderly African American Females of Low Socioeconomic Status
Vol. 42, No. 1 47 Clinical Research and Methods Vitamin D, Sunlight Exposure, and Bone Density in Elderly African American Females of Low Socioeconomic Status Sally P. Weaver, PhD, MD; Cindy Passmore,
More informationManagement of postmenopausal osteoporosis
Management of postmenopausal osteoporosis Yeap SS, Hew FL, Chan SP, on behalf of the Malaysian Osteoporosis Society Committee Working Group for the Clinical Guidance on the Management of Osteoporosis,
More informationCalcium and Vitamin D Supplementation in Postmenopausal Women. Winthrop University Hospital, Bone Mineral Research Center, Mineola, New York 11501
JCEM ONLINE Hot Topics in Translational Endocrinology Endocrine Care Calcium and Vitamin D Supplementation in Postmenopausal Women John F. Aloia, Ruban Dhaliwal, Albert Shieh, Mageda Mikhail, Shahidul
More informationAlex Chin. Opinion Letter VITAMIN D ANA. Dr. Alex Chin T2L 2K8. in laboratory
Vitamin D Analyte of thee Millennium OPINION LETTER VITAMIN Alex Chin D ANA Calgary Laboratory Services, Calgary, Alberta Canadaa & Department of Pathology and Laboratory Medicine, University of Calgary,
More informationWhereas serum concentrations of 25-hydroxyvitamin D
ORIGINAL ARTICLE Endocrine Care Urban Tropospheric Ozone Increases the Prevalence of Vitamin D Deficiency among Belgian Postmenopausal Women with Outdoor Activities during Summer Daniel-Henri Manicourt
More informationEfficacy of different doses and time intervals of oral vitamin D supplementation with or without calcium in elderly nursing home residents
Osteoporos Int (2008) 19:663 671 DOI 10.1007/s00198-007-0465-2 ORIGINAL ARTICLE Efficacy of different doses and time intervals of oral vitamin D supplementation with or without calcium in elderly nursing
More informationTHE SUNSHINE VITAMIN. Maureen Molini, MPH, RDN, CSSD University of Nevada Reno Student Health Services
THE SUNSHINE VITAMIN Maureen Molini, MPH, RDN, CSSD University of Nevada Reno Student Health Services Vitamin vs. Prohormone Technically not a vitamin since it isn t obtained solely through diet Synthesized
More informationPrevalence Of Vitamin D Inadequacy In Peri And Postmenopausal Women Presented At Dow University Hospital, Ojha Campus. A Cross Sectional Study
ISPUB.COM The Internet Journal of Nutrition and Wellness Volume 12 Number 1 Prevalence Of Vitamin D Inadequacy In Peri And Postmenopausal Women Presented At Dow University S Shukar-ud-din, R Tabassum,
More informationHigh Prevalence of Vitamin D Insufficiency in China: Relationship with the Levels of Parathyroid Hormone and Markers of Bone Turnover
High Prevalence of Vitamin D Insufficiency in China: Relationship with the Levels of Parathyroid Hormone and Markers of Bone Turnover Han-Kui Lu 1., Zeng Zhang 2,3., Yao-Hua Ke 2, Jin-Wei He 2, Wen-Zhen
More information